Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
about
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysisUse of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersWomen's preferences for selective estrogen reuptake modulators: an investigation using the time trade-off technique.iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concerns.Heightened perception of breast cancer risk in young women at risk of familial breast cancer.Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles.Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
P2860
Q26773464-A5AFD986-77E7-452F-A246-C57C361B5F6CQ34475484-82B40C1F-37B4-447D-BD07-92737FD9A796Q35661551-AFFDE3EC-2B8A-42A0-B91B-D1A0DD7D4C00Q36678510-DC0C9312-B9DA-4D47-AB05-0B1782728180Q37219731-917DBA16-8DC1-4017-B02A-08728055A872Q38253136-8C50B2C8-C9DD-4D4E-9EC7-272A56BF74FDQ38684207-569CD0B6-FE74-4384-A27D-328E9A317173Q42428131-1E90D0EA-87A0-4D4C-9224-38492EAFFA3EQ43624639-170D2772-D07D-41ED-B20F-8D62DA4E1AC1Q50091589-102D11B6-957D-4A52-92FF-18DD3C8C33D9Q50195463-23B1517E-0CCE-423D-BF43-1412A65C50F9Q55243290-4BCDB7BA-4229-44AE-82E1-098E50BCDFDA
P2860
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
@en
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
@nl
type
label
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
@en
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
@nl
prefLabel
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
@en
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
@nl
P2093
P50
P356
P1476
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
@en
P2093
John L Hopper
Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer
Michael L Friedlander
Roger L Milne
Sue-Anne McLachlan
P304
P356
10.5694/MJA13.10848
P407
P577
2013-11-01T00:00:00Z